173 related articles for article (PubMed ID: 15875041)
1. Personalized medicine prompts push to redesign clinical trials.
Singer E
Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
[No Abstract] [Full Text] [Related]
2. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
3. The disruptive nature of personalized medicine technologies: implications for the health care system.
Carlson RJ
Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
[TBL] [Abstract][Full Text] [Related]
4. What is clinical utility and why should we care?
Lesko LJ; Zineh I; Huang SM
Clin Pharmacol Ther; 2010 Dec; 88(6):729-33. PubMed ID: 21081937
[No Abstract] [Full Text] [Related]
5. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
6. The conundrum of personalized cancer management, drug development, and economics.
DeNardo GL
Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
[No Abstract] [Full Text] [Related]
7. The future of highly personalized health care.
Robson B; Garnier J
Stud Health Technol Inform; 2002; 80():163-74. PubMed ID: 12026125
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics: the promise of personalized medicine.
Hood E
Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
[No Abstract] [Full Text] [Related]
9. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
10. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
Musgrave E
Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
[No Abstract] [Full Text] [Related]
11. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
12. Getting to personalized cancer medicine: taking out the garbage.
Compton C
Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
[No Abstract] [Full Text] [Related]
13. Translating pharmacogenomics: challenges on the road to the clinic.
Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
[TBL] [Abstract][Full Text] [Related]
14. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
Frueh FW; Gurwitz D
Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging and personalized medicine: an uncertain future.
Nunn AD
Cancer Biother Radiopharm; 2007 Dec; 22(6):722-39. PubMed ID: 18158763
[TBL] [Abstract][Full Text] [Related]
16. Four important steps toward 21st century care for patients with cancer.
McClellan M; Benner JS
Oncologist; 2009 Apr; 14(4):313-6. PubMed ID: 19365095
[No Abstract] [Full Text] [Related]
17. Progress toward personalized medicine for age-related macular degeneration.
Moroi SE; Heckenlively JR
Ophthalmology; 2008 Jun; 115(6):925-6. PubMed ID: 18519068
[No Abstract] [Full Text] [Related]
18. Does comparative-effectiveness research threaten personalized medicine?
Garber AM; Tunis SR
N Engl J Med; 2009 May; 360(19):1925-7. PubMed ID: 19420360
[No Abstract] [Full Text] [Related]
19. How molecular medicine transforms policy (and everything else).
Kean MA; Batchelder KF
J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics: on the road to 'personalized medicine'.
Woodcock J
FDA Consum; 2005; 39(6):44. PubMed ID: 16669118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
